Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -6.13 | -17.78 |
PEG Ratio (TTM) | 0.07 | -5.55 |
P/S Ratio (TTM) | 0.60 | 39.43 |
P/B Ratio (TTM) | 0.89 | 5.80 |
P/FCF Ratio (TTM) | -3.94 | -146.47 |
Price to 5YR AVG Earnings Ratio | N/A | -34.01 |
Price to 5YR AVG FCF Ratio | N/A | -1.00 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.16% | 288.99% |
ROE (TTM) | -16.22% | -4,244.29% |
Net Profit Margin (TTM) | -9.61% | -1,050.76% |
ROIC 5YR AVG | N/A | -15.85% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1,722.86% | -5,764.75% | N/A |
Revenue | -30.27% | N/A | N/A |
Net Income | -1,401.04% | -7,337.69% | N/A |
Cash Flow | -1,284.29% | -10,283.98% | N/A |
Health (40%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.96 | 4.94 |
Quick Ratio (TTM) | 1.64 | 4.92 |
D/E Ratio (TTM) | 0.54 | 1.30 |
Interest Coverage (TTM) | -2.19 | -11.46 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 1.16 | 21.03 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 892.04% |